KRYSTAL BIOTECH, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 161.1 USD | +0.54% |
|
+2.69% | +29.86% |
Chart calendar Krystal Biotech, Inc.
429b8b91f303ba94f835a4c7a4.-YVyOI8eYkYb_1Z59KQZbO6nUlL9oaYWqX3jkG9N00w.oag2QttNNiddtC8OptFWJKOWEWGp5MQjwEmR_AAUg3yc7AYNv0QxKkKwIQ~8d0a307e43234d9ae70d59e0d27e1f31
Upcoming events on Krystal Biotech, Inc.
Past events on Krystal Biotech, Inc.
| 10/04/2024 17:00 | American Association for Cancer Research Meeting - Presentation Number 7260 |
| 05/03/2024 14:50 | TD Cowen Health Care Conference - Fireside Chat |
| 26/02/2024 13:30 | Q4 2023 Earnings Call |
| 26/02/2024 13:00 | Q4 2023 Earnings Release |
| 07/02/2024 15:00 | Guggenheim Healthcare Talks Biotechnology Conference |
| 15/11/2023 16:30 | Stifel Healthcare Conference - Fireside Chat |
| 06/11/2023 13:30 | Q3 2023 Earnings Call |
| 06/11/2023 12:00 | Q3 2023 Earnings Release |
| 03/10/2023 16:30 | Chardan Genetic Medicines Conference |
| 12/09/2023 21:55 | Morgan Stanley Global Healthcare Conference - Fireside Chat |
| 27/07/2023 13:00 | Business Update Call |
| 13/06/2023 16:00 | Goldman Sachs Global Healthcare Conference |
| 06/06/2023 16:40 | William Blair Growth Stock Conference |
| 19/05/2023 23:00 | VYJUVEK FDA Approval Call |
| 19/05/2023 21:00 | Annual General Meeting |
| 08/05/2023 13:23 | Q1 2023 Earnings Release |
| 23/04/2023 18:00 | Association for Research in Vision and Ophthalmology Meeting - Presentation Number: C0388 |
| 07/03/2023 15:30 | Cowen Health Care Conference - Fireside Chat |
| 27/02/2023 12:00 | Q4 2022 Earnings Release |
| 07/12/2022 19:20 | Bank of America Biotech SMID Cap Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 50,7 36,3 39.61% | 260 |
|
EBITDA Million USD | Released Forecast Spread | -21,3 -21,3 -0.34% | -31,1 -34,6 10.08% | -65,5 -60,4 -8.37% | -144 -139 -3.36% | -106 -120 11.9% | 66,3 |
|
EBIT Million USD | Released Forecast Spread | -22,1 -22,2 0.54% | -33,0 -34,8 5.21% | -68,3 -63,2 -8.1% | -145 -145 -0.19% | -110 -129 14.79% | 46,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -19,1 -19,9 3.89% | -32,2 -33,4 3.82% | -69,6 -63,2 -10.17% | -140 -142 1.29% | 12,9 -10,4 223.68% | 55,4 |
|
Net income Million USD | Released Forecast Spread | -19,1 -19,9 3.88% | -32,2 -33,4 3.82% | -69,6 -63,7 -9.28% | -140 -142 1.53% | 10,9 -12,6 186.91% | 43,5 |
|
EPS USD | Released Forecast Spread | -1,20 -1,21 0.99% | -1,71 -1,76 3.02% | -3,13 -2,89 -8.21% | -5,49 -5,56 1.24% | 0,39 -0,36 209.34% | 1,90 |
| Announcement Date | 10/03/20 | 01/03/21 | 28/02/22 | 27/02/23 | 26/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,17 - | 0,00 0,00 - | 8,56 6,29 35.97% | 42,1 29,9 40.82% | 47,4 | 60,6 | 71,7 | 80,6 | |
|
EBITDA Million USD | Released Forecast Spread | -21,1 -18,0 -17.05% | 4,30 -11,4 137.79% | 18,2 | 33,8 | 45,6 | 51,5 | ||||||||
|
EBIT Million USD | Released Forecast Spread | -21,9 -16,7 -31.24% | -25,2 -27,5 8.23% | -28,8 -26,5 -8.32% | -31,5 -32,8 4.24% | -34,8 -34,7 -0.23% | -48,8 -41,3 -18.23% | -38,0 -38,9 2.13% | -26,0 -35,9 27.59% | 3,14 -16,4 119.09% | 3,08 | 10,7 | 17,8 | 17,3 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -21,8 -16,8 -29.8% | -50,0 -28,7 -74.09% | -28,1 -27,5 -2.33% | -29,9 -34,0 12.1% | -32,1 -34,0 5.64% | -45,3 -36,9 -22.84% | -33,2 -17,0 -95.16% | 80,7 -12,6 740.25% | 10,7 -14,4 174.02% | 4,93 | 14,3 | 18,4 | 18,5 | |
|
Net income Million USD | Released Forecast Spread | -21,8 -17,1 -27.64% | -50,0 -28,7 -74.09% | -28,1 -27,5 -2.33% | -29,9 -34,0 12.1% | -32,1 -34,0 5.64% | -45,3 -36,9 -22.84% | -33,2 -17,0 -95.16% | 80,7 -15,7 613.45% | 8,69 -14,2 161.01% | 4,02 | 11,0 | 14,1 | 13,8 | |
|
EPS USD | Released Forecast Spread | -0,95 -0,73 -29.88% | -1,99 -1,07 -86.85% | -1,10 -1,04 -6.28% | -1,17 -1,22 3.87% | -1,25 -0,99 -26.45% | -1,76 -1,48 -19.05% | -1,25 -0,74 -69.68% | 2,79 -0,67 515.53% | 0,31 -0,39 178.98% | 0,15 | 0,38 | 0,63 | 0,66 | 0,72 |
| Announcement Date | 28/02/22 | 09/05/22 | 08/08/22 | 07/11/22 | 27/02/23 | 08/05/23 | 07/08/23 | 06/11/23 | 26/02/24 | - | - | - | - | - |
More events
Past sector events for Krystal Biotech, Inc.
| 02/05/2024 21:05 | KURA ONCOLOGY, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:05 | ZYMEWORKS INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:02 | ARDELYX, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:01 | LONGBOARD PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:01 | ASCENDIS PHARMA A/S: Q1 2024 Earnings Release |
| 02/05/2024 21:00 | ULTRAGENYX PHARMACEUTICAL INC.: Q1 2024 Earnings Release |
| 02/05/2024 16:00 | GENMAB A/S: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | GERON CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | AGIOS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | BICYCLE THERAPEUTICS PLC: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- KRYS Stock
- Calendar Krystal Biotech, Inc.
